Cargando…
Discovery of Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin L
One inhibitor of the main SARS-CoV-2 protease has been approved recently by the FDA, yet it targets only SARS-CoV-2 main protease (Mpro). Here, we discovered inhibitors containing thiuram disulfide or dithiobis-(thioformate) tested against three key proteases involved in SARS-CoV-2 replication, incl...
Autores principales: | Meewan, Ittipat, Kattoula, Jacob, Kattoula, Julius Y., Skinner, Danielle, Fajtová, Pavla, Giardini, Miriam A., Woodworth, Brendon, McKerrow, James H., Lage de Siqueira-Neto, Jair, O’Donoghue, Anthony J., Abagyan, Ruben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230533/ https://www.ncbi.nlm.nih.gov/pubmed/35745663 http://dx.doi.org/10.3390/ph15060744 |
Ejemplares similares
-
Allosteric Inhibitors of Zika Virus NS2B-NS3 Protease Targeting Protease in “Super-Open” Conformation
por: Meewan, Ittipat, et al.
Publicado: (2023) -
Discovery of New Inhibitors of Hepatitis C Virus NS3/4A
Protease and Its D168A Mutant
por: Meewan, Ittipat, et al.
Publicado: (2019) -
Enantioselective inhibition of the SARS-CoV-2 main protease with rhenium(i) picolinic acid complexes
por: Karges, Johannes, et al.
Publicado: (2022) -
Dissecting the Active Site of the Collagenolytic Cathepsin L3 Protease of the Invasive Stage of Fasciola hepatica
por: Corvo, Ileana, et al.
Publicado: (2013) -
A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells
por: Mellott, Drake M., et al.
Publicado: (2020)